News

The primary objective of the studies is to evaluate the safety and tolerability of treatment with Amigal, while the secondary objective is to evaluate certain pharmacodynamic measures of

Since 1995, new cases of reported acute hepatitis A have declined by 88%, while the number of hepatitis B and C cases have also dropped, the Centers for

Tracon will pay Micromet upfront and milestone payments of more than $100 million, if D93 is successfully developed and commercialized. In addition, Micromet will receive royalties on worldwide

Retinoblastoma forms when developing cells in the retina start to divide uncontrollably, and usually occurs in children under six. The disease is fatal if left untreated. Although chemotherapy

The Department of Health and Human Services (HHS) told the drug developer that the amount of data available for Neumune was not sufficient to justify the advance purchase

MedImmune needs the expanded capability to meet its commitments to a five-year, approximately $170 million contract awarded last year by the US government. “While we are currently expanding

Autism is thought to be the most highly heritable of all neuro-psychiatric disorders. However, new research, from a team led by Cold Spring Harbor Laboratory (CSHL) scientists Jonathan

The drug is a small molecule inhibitor of phosphoinositide-3 kinase (PI3K). Activation of PI3K is a frequent event in human tumors, promoting tumor cell growth, survival, and resistance

The news follows an announcement from the FDA that it would still need an additional three-year study on the drug before approval in the US, rejecting an appeal